Neurocrine

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Neurocrine and other ETFs, options, and stocks.

About NBIX

Neurocrine Biosciences, Inc. is a neuroscience-focused, biopharmaceutical company, which engages in the research, development, and commercialization of pharmaceuticals for the treatment of neurological, neuroendocrine, and neuropsychiatric disorders. The company was founded by Kevin C.

CEO

Kevin Charles Gorman

CEOKevin Charles Gorman

Employees

1,400

Employees1,400

Headquarters

San Diego, California

HeadquartersSan Diego, California

Founded

1992

Founded1992

Employees

1,400

Employees1,400

NBIX Key Statistics

Market cap

13.17B

Market cap13.17B

Price-Earnings ratio

53.89

Price-Earnings ratio53.89

Dividend yield

—

Dividend yield—

Average volume

708.57K

Average volume708.57K

High today

$134.15

High today$134.15

Low today

$131.51

Low today$131.51

Open price

$133.23

Open price$133.23

Volume

549.31K

Volume549.31K

52 Week high

$148.37

52 Week high$148.37

52 Week low

$89.04

52 Week low$89.04

NBIX News

TipRanks 2d

Neurocrine, Sentia Medical Sciences extend CRF research collaboration

Sentia Medical Sciences announced that they have further extended a research collaboration with Neurocrine Biosciences aimed at discovering novel, long-acting c...

Analyst ratings

68%

of 28 ratings

Buy

67.9%

Hold

32.1%

Sell